SE449005B - Reagens for undanrojande av turbiditet i ett biologiskt prov - Google Patents
Reagens for undanrojande av turbiditet i ett biologiskt provInfo
- Publication number
- SE449005B SE449005B SE8105737A SE8105737A SE449005B SE 449005 B SE449005 B SE 449005B SE 8105737 A SE8105737 A SE 8105737A SE 8105737 A SE8105737 A SE 8105737A SE 449005 B SE449005 B SE 449005B
- Authority
- SE
- Sweden
- Prior art keywords
- surfactant
- reagent
- acid diethanolamide
- enzyme
- cholesterol
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 34
- 238000012360 testing method Methods 0.000 title description 3
- 239000004094 surface-active agent Substances 0.000 claims description 29
- 102000004190 Enzymes Human genes 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 22
- 108010055297 Sterol Esterase Proteins 0.000 claims description 16
- 102000000019 Sterol Esterase Human genes 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical group CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 claims description 14
- 229940031957 lauric acid diethanolamide Drugs 0.000 claims description 14
- 239000012472 biological sample Substances 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- 108090001060 Lipase Proteins 0.000 claims description 11
- 102000004882 Lipase Human genes 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 239000004367 Lipase Substances 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 10
- 235000019421 lipase Nutrition 0.000 claims description 10
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical group OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 claims description 4
- 244000060011 Cocos nucifera Species 0.000 claims description 3
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- BPXGKRUSMCVZAF-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)decanamide Chemical compound CCCCCCCCCC(=O)N(CCO)CCO BPXGKRUSMCVZAF-UHFFFAOYSA-N 0.000 claims description 3
- SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- -1 p-isooctyl phenyl Chemical group 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000012925 reference material Substances 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 42
- 235000012000 cholesterol Nutrition 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 18
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 238000005352 clarification Methods 0.000 description 7
- 230000001000 lipidemic effect Effects 0.000 description 7
- 150000001840 cholesterol esters Chemical class 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 108010089254 Cholesterol oxidase Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- SHPKCSFVQGSAJU-UAIGNFCESA-L dipotassium;(z)-but-2-enedioate Chemical compound [K+].[K+].[O-]C(=O)\C=C/C([O-])=O SHPKCSFVQGSAJU-UAIGNFCESA-L 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004923 pancreatic tissue Anatomy 0.000 description 3
- OFGDSGVGRWPQJQ-UHFFFAOYSA-N 1h-imidazol-1-ium;acetate Chemical compound CC(O)=O.C1=CNC=N1 OFGDSGVGRWPQJQ-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 239000008137 solubility enhancer Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000008395 clarifying agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ZLVSYODPTJZFMK-UHFFFAOYSA-M sodium 4-hydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C=C1 ZLVSYODPTJZFMK-UHFFFAOYSA-M 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035024 thioglycerol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19265180A | 1980-10-01 | 1980-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8105737L SE8105737L (sv) | 1982-04-02 |
| SE449005B true SE449005B (sv) | 1987-03-30 |
Family
ID=22710512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8105737A SE449005B (sv) | 1980-10-01 | 1981-09-29 | Reagens for undanrojande av turbiditet i ett biologiskt prov |
Country Status (11)
| Country | Link |
|---|---|
| JP (2) | JPS5780560A (de) |
| AU (1) | AU543239B2 (de) |
| BE (1) | BE890479A (de) |
| CA (1) | CA1163908A (de) |
| CH (1) | CH657919A5 (de) |
| DE (1) | DE3138602A1 (de) |
| FR (1) | FR2495184B1 (de) |
| GB (1) | GB2084726B (de) |
| IT (1) | IT1144750B (de) |
| NL (1) | NL8104304A (de) |
| SE (1) | SE449005B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60227171A (ja) * | 1984-04-25 | 1985-11-12 | Sogo Seibutsu Igaku Kenkyusho:Kk | ヘモグロビンに結合したグルコ−スの測定方法 |
| FR2599149B1 (fr) * | 1986-05-21 | 1988-08-26 | Univ Nancy | Reactif pour la transparisation de milieux biologiques et ses applications analytiques. |
| DE3620817A1 (de) * | 1986-06-21 | 1987-12-23 | Boehringer Mannheim Gmbh | Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch |
| EP1013774B8 (de) | 1998-12-22 | 2006-12-06 | Olympus Life and Material Science Europa GmbH | Flüssigreagenz für den Nachweis von Kreatinkinase |
| JP4709739B2 (ja) | 2003-02-28 | 2011-06-22 | イーエルシー マネージメント エルエルシー | 毛髪成長の増進方法 |
| JP2006071574A (ja) * | 2004-09-06 | 2006-03-16 | Denka Seiken Co Ltd | 免疫比濁法及びそのための試薬 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2089212A (en) * | 1936-06-08 | 1937-08-10 | Kritchevsky Wolf | Hydrotropic fatty material and method of making same |
| US2531190A (en) * | 1946-11-12 | 1950-11-21 | Drew & Co Inc E F | Emulsifier consisting of alkylolamine-fatty acid condensation products and esters ofpolyglycols |
| US3260648A (en) * | 1963-08-16 | 1966-07-12 | Warner Lambert Pharmaceutical | Diagnostic aid |
| US3853465A (en) * | 1972-06-09 | 1974-12-10 | Technicon Instr | Turbidity reduction in serum and plasma samples using polyoxyethylated lauric acid compounds |
| US3898130A (en) * | 1974-03-18 | 1975-08-05 | American Hospital Supply Corp | Rapid enzymatic hydrolysis of triglycerides |
| DE2724757C2 (de) * | 1977-06-01 | 1979-08-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Mittel zur Beseitigung von Trübungen in Serum und Verfahren zu seiner Herstellung |
| DE2816229C2 (de) * | 1978-04-14 | 1983-11-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Mittel zur Beseitigung von Trübungen |
-
1981
- 1981-06-23 CA CA000380441A patent/CA1163908A/en not_active Expired
- 1981-07-15 AU AU72876/81A patent/AU543239B2/en not_active Ceased
- 1981-07-30 IT IT68070/81A patent/IT1144750B/it active
- 1981-08-27 JP JP56133441A patent/JPS5780560A/ja active Granted
- 1981-09-18 NL NL8104304A patent/NL8104304A/nl not_active Application Discontinuation
- 1981-09-24 BE BE0/206050A patent/BE890479A/fr not_active IP Right Cessation
- 1981-09-24 GB GB8128928A patent/GB2084726B/en not_active Expired
- 1981-09-28 FR FR8118203A patent/FR2495184B1/fr not_active Expired
- 1981-09-29 SE SE8105737A patent/SE449005B/sv not_active IP Right Cessation
- 1981-09-29 DE DE19813138602 patent/DE3138602A1/de active Granted
- 1981-10-01 CH CH6335/81A patent/CH657919A5/de not_active IP Right Cessation
-
1989
- 1989-04-18 JP JP1096552A patent/JPH01304898A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2495184A1 (fr) | 1982-06-04 |
| BE890479A (fr) | 1982-03-24 |
| DE3138602C2 (de) | 1993-02-11 |
| AU7287681A (en) | 1982-04-08 |
| GB2084726A (en) | 1982-04-15 |
| GB2084726B (en) | 1983-11-23 |
| CA1163908A (en) | 1984-03-20 |
| DE3138602A1 (de) | 1982-06-24 |
| CH657919A5 (de) | 1986-09-30 |
| NL8104304A (nl) | 1982-05-03 |
| JPH0474000B2 (de) | 1992-11-25 |
| IT8168070A0 (it) | 1981-07-30 |
| JPH0151782B2 (de) | 1989-11-06 |
| SE8105737L (sv) | 1982-04-02 |
| FR2495184B1 (fr) | 1985-06-28 |
| JPS5780560A (en) | 1982-05-20 |
| AU543239B2 (en) | 1985-04-04 |
| IT1144750B (it) | 1986-10-29 |
| JPH01304898A (ja) | 1989-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Allain et al. | Enzymatic determination of total serum cholesterol | |
| Bucolo et al. | Quantitative determination of serum triglycerides by the use of enzymes | |
| Kattermann et al. | Multicentre study of a new enzymatic method of cholesterol determination | |
| US4543326A (en) | Stabilization of oxidase | |
| US4892815A (en) | Process and reagent for the specific determination of the cholesterol of the HDL fraction | |
| CN101061234B (zh) | 用于脂肪酶活性测定的组合物以及活性测定方法 | |
| EP0019253B1 (de) | Probevorrichtung, Zusammensetzung und Verfahren zur Bestimmung von Triglyceriden | |
| CN107287277B (zh) | 小而密低密度脂蛋白胆固醇检测试剂盒 | |
| DE60100241T2 (de) | Verfahren und Reagenz zur Bestimmung von Cholesterin in Rest-Lipoproteinpartikeln (Remnante Partikel) | |
| US4503146A (en) | Method for eliminating turbidity in a biological fluid and reagent therefor | |
| SE449005B (sv) | Reagens for undanrojande av turbiditet i ett biologiskt prov | |
| JPH08116996A (ja) | 血清または血漿中のｈｄｌ−コレステロールを測定する方法 | |
| US4816411A (en) | Method for eliminating turbidity in a biological fluid and reagent therefor | |
| JPH01108997A (ja) | 血液又は血液から導出した試料中の血清のフルクトスアミン含量を特異的に測定する方法及び試薬、及び非特異的還元作用を有するか、又は／及び溷濁を惹起する試料成分を除去する方法 | |
| EP1020532A1 (de) | Methode und reagenzien zum bestimmen von substanzen in biologischen proben | |
| CA1198040A (en) | Stabilized enzymatic solutions and methods for determining total cholesterol in human serum | |
| EP3181689B1 (de) | Verfahren zur herstellung einer substratlösung zur messung der lipaseaktivität und verfahren zur vereinfachung der herstellung | |
| JP4130724B2 (ja) | キレート物質を含む測定試薬 | |
| Curreri et al. | Increased activity of lysosomal enzymes in experimental atherosclerosis, and the effect of cortisone | |
| US4007091A (en) | Method for measuring the activity of lecithin cholesterol acyl transferase and lecithin substrate solution useful therefor | |
| JP4013108B2 (ja) | リパーゼの安定化方法 | |
| JPH0367600A (ja) | リパーゼ定量用単一試薬系およびその製造方法 | |
| CN110029145A (zh) | 低密度脂蛋白胆固醇测定试剂、其制备方法及其使用方法 | |
| CN112710609B (zh) | 抗乳糜干扰的尿酸测定试剂盒 | |
| JP2003000236A (ja) | エステラーゼの安定化方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8105737-4 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8105737-4 Format of ref document f/p: F |